Azerbaijan vs Malawi: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Azerbaijan
0.3%
in 2024
Malawi
0.3%
in 2024
Azerbaijan rank
67th
Malawi rank
67th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Azerbaijan
- Malawi
How they compare
Azerbaijan currently reports 0.3% against 0.3% in Malawi, a difference of 0.0%.
Across all 10 years both countries report, Malawi has been ahead every year.
Azerbaijan ranks 67th and Malawi ranks 67th of 215 countries.
Malawi has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.5% | 0.3% | Malawi |
| 2020s | 0.3% | 0.4% | 0.1% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Azerbaijan or Malawi?
- Azerbaijan, at 0.3% against 0.3% in Malawi as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Azerbaijan and Malawi?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Malawi?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Malawi rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Azerbaijan ranks 67th and Malawi ranks 67th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.